Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
Urbano Anido Herranz, N. Fernández Núñez, Francisco Javier Afonso Afonso, Lucía Santomé Couto, Ana Medina Colmenero, Ovidio Fernández Calvo, Martin Lázaro Quintela, Sergio Vázquez Estévez
págs. 249-258
Classical Protein Kinase C: a novel kinase target in breast cancer
R.K. Singh, S. Kumar, M.S. Tomar, P.K. Verma, S.P. Singh, P.K. Gautam, A. Acharya
págs. 259-267
Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
B. Farhood, N.H. Goradel, K. Mortezaee, N. Khanlarkhani, E. Salehi, M.S. Nashtaei, H. Mirtavoos-mahyari, E. Motevaseli, D. Shabeeb, A.E. Musa, M. Najafi
págs. 268-279
Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder
E. El Rassy, T. Assi, Z. Bakouny, Nicholas Pavlidis, J. Kattan
págs. 280-288
Ana María García Vicente, Beatriz González García, Mariano Amo Salas, I. García Carbonero, Javier Cassinello Espinosa, José Lorenzo Gómez-Aldaraví Gutiérrez, L. Suarez Hinojosa, Angel Soriano Castrejón
págs. 289-297
págs. 298-303
The Medical Oncology resident mentor: situation and workload
Elena Élez Fernández, M.T. Quintanar Verdúguez, Joaquim Bosch Barrera, J. Corral, Nuria Láinez Milagro, Víctor Moreno García, César Augusto Rodríguez Sánchez, E. González Flores, Andrés Cervantes Ruiperez
págs. 304-313
Effectiveness, safety and cost of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world data analysis
Manuel Koninckx Cañada, J.L. Marco Garbayo, Mª Teresa Faus Soler, V. Alcolea, Fernando Gómez Pajares, Isabel Pérez Castelló
págs. 314-323
Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at 18F-FDG–PET/CT: prognostic implication of metabolic parameters and tumor markers
Aida Sabaté Llobera, Laura Maria Gràcia Sanchez, G. Reynés Llompart, Emilio Ramos Rubio, Laura Lladó Garriga, Javier Robles Barba, Teresa Serrano Piñol, J. Mestres Martí, Cristina Gámez Cenzano
págs. 324-333
págs. 334-341
T.M. Morgan, X. Wang, X. Qian, J.M. Switchenko, S. Nie, K.R. Patel, R.J. Cassidy, D.M. Shin, Jonathan J. Beitler
págs. 342-347
Lung cancer patients with a previous extra-pulmonary malignancy should not be considered homogeneous: a clinicopathological analysis of 3530 surgical cases
X.L. Hu, S.T. Xu, X.C. Wang, D.N. Hou, C. Bao, D. Yang, Y.L. Song
págs. 348-354
Francesc Casas, Izaskun Valduvieco Ruiz, G. Oses, Laura Izquierdo Reyes, I. Archila, Josep Costa Camps, K. S. Cortés, T. Barreto, Ferran Ferrer González
págs. 355-362
V. Chung, F.J. Kos, N. Hardwick, Y. Yuan, J. Chao, D. Li, J. Waisman, M. Li, K. Zurcher, P. Frankel, D.J. Diamond
págs. 363-372
Retroperitoneal fibrosis secondary to non-urology carcinomas: a clinical and outcome analysis of 97 cases
págs. 373-379
Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP)
Carlos Camps Herrero, J. J. Reina Zoiló, Diana Monge Monge, F. Caballero Martínez, Vicente Guillem Porta, Enrique Aranda Aguilar, Alfredo Carrato Mena, Eduardo Díaz-Rubio García, Jesús García-Foncillas López, Margarita Feyjoo Saus, Rafael López López
págs. 380-390
© 2001-2024 Fundación Dialnet · Todos los derechos reservados